Skip to main content
. 2019 Nov 7;27:104768. doi: 10.1016/j.dib.2019.104768

Table 2.

Relative Risk (95% CI) of in-hospital mortality for critical patients admitted during the ECS period with respect to the pre-ECS period, according to patients' characteristics at admission.

Patients, n [pre-ECS:ECS] Day 0
Day 1–28
Day 0–28
Patients, n [pre-ECS:ECS] RRa (IC 95%) p-valueb Patients, n [pre-ECS:ECS] RRa (IC 95%) p-valueb Patients, n [pre-ECS:ECS] RRa (IC 95%) p-valueb
Age, years
18–64 89:89 5:8 1.6 (0.52; 4.89) 0.7 9:8 0.92 (0.36; 2.39) 0.6 14:16 1.14 (0.56; 2.34) 0.9
≥65 29:28 3:3 1.04 (0.21; 5.13) 6:8 1.39 (0.48; 4) 9:11 1.27 (0.52; 3.05)
AIS head
<4 83:85 2:2 0.98 (0.14; 6.93) 0.6 6:8 1.3 (0.45; 3.75) 0.8 8:10 1.22 (0.48; 3.09) 1.0
≥4 35:32 6:9 1.64 (0.58; 4.61) 9:8 1.12 (0.43; 2.9) 15:17 1.24 (0.62; 2.48)
Inclusion criteria, n
1 67:60 0:5 NE 8:7 0.95 (0.34; 2.61) 0.7 8:12 1.5 (0.61; 3.67) 0.5
≥2 51:50 8:6 0.77 (0.27; 2.2) 7:9 1.26 (0.47; 3.37) 15:15 1.02 (0.5; 2.09)

AIS = anatomical injury score; BE = base excess; NE = not estimable (no events); RR = relative risk; SBP = systolic blood pressure.

a

Relative Risk of mortality for patients in the ECS study period vs. patients in the pre-ECS period (reference) with 95% CI, from Poisson regression model. A number lower than 1 indicates a reduction in the mortality risk for patients in the ECS with respect to the pre-ECS period.

b

p-value to test interaction between patients' characteristics and mortality RR (F-test).